2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
36
5b
1d
2 29
1d
25
Melanie Ruffner, MD, PhD
78
5b
Assistant Professor of Pediatrics (Allergy/Immunology)
7
61
Department: Pediatrics
4
1
23
1f
Graduate Group Affiliations
8
b
-
6b
- Cell and Molecular Biology 5c
- Immunology e
1d
46
Contact information
53
4
3
3
1d
53
Children’s Hospital of Philadelphia
2a Division of Allergy and Immunology
1f 3615 Civic Center Blvd.
42 Abramson Research Center, 1202C
Philadelphia, PA 19104
26
2a Division of Allergy and Immunology
1f 3615 Civic Center Blvd.
42 Abramson Research Center, 1202C
Philadelphia, PA 19104
2c
Office: 2155902549
30 Fax: 2155906849
30 Lab: 2674253074
18
f
30 Fax: 2155906849
30 Lab: 2674253074
18
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 B.S. 23 (Biomedical Engineering) c
31 Johns Hopkins University, 2003.
21 a Ph.D. 1b (Bioengineering) c
44 University of Pittsburgh School of Medicine, 2009.
21 9 M.D. 15 (Medicine) c
44 University of Pittsburgh School of Medicine, 2011.
21 9 M.S. 23 (Translational Research) c
46 University of Pennsylvania School of Medicine, 2020.
c
3
27
21 9 B.S. 23 (Biomedical Engineering) c
31 Johns Hopkins University, 2003.
21 a Ph.D. 1b (Bioengineering) c
44 University of Pittsburgh School of Medicine, 2009.
21 9 M.D. 15 (Medicine) c
44 University of Pittsburgh School of Medicine, 2011.
21 9 M.S. 23 (Translational Research) c
46 University of Pennsylvania School of Medicine, 2020.
c
Links
e2 Search PubMed for articles
d
5
3
3
92
Permanent linke2 Search PubMed for articles
d
2 29
21
1e
1d
24
2b
29
27
23
17a Spergel BL, Ruffner MA, Godwin BC, Liacouras CA, Cianferoni A, Gober L, Hill DA, Brown-Whitehorn TF, Chaiboonma K, Aceves SA, Muir AM, Spergel JM: Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use. Ann Allergy Asthma Immunol 128(5): 589-593, May 2022.
155 Tran P, Gober L, Garabedian EK, Fuleihan RL, Puck JM, Sullivan KE, Spergel JM, Ruffner MA: Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry. Front Immunol 13(987895): doi: 10.3389, Sep 2022 Notes: epub.
14e Ruffner MA*, Hu A*, Dilollo J, Benocek K, Shows D, Gluck M, Spergel JM, Ziegler SF, Hill DA, Cerosaletti K (*contributed equally): Conserved interferon signature in adult and pediatric eosinophilic esophagitis. Journal of Immunology 206(6): 1361-1371, Mar 2021.
152 Benitez AJ, Bittinger K, Tanes C, Hofstaedter CE, Kim DK, Gross J, Ruffner MA, Albenberg L, Spergel JM, Muir AB: Effect of topical swallowed steroids on the bacterial and fungal esophageal microbiota in eosinophilic esophagitis. Allergy 76(5): 1549-1552, May 2021.
151 Ruffner MA, Zhang Z, Maurer K, Muir AB, Cianferoni C, Sullivan KE, Spergel JS: RNA sequencing identifies global transcriptional changes in peripheral CD4 + cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitis. Clin Transl Immunology 2d 10(7): e1314, July 2021.
c8 Ruffner MA, Song L, Mauer K, Shi L, Wang JX, Muir AB, Spergel JM, Sullivan KE: Toll like receptor 2 stimulation augments esophageal barrier integrity 3d Allergy 74(12): 2449-2460, Dec 2019.
139 Ruffner MA, Wang KY, Dudley JW, Cianferoni A, Grundemeier R, Spergel JM, Brown-Whitehorn TF, Hill DA: Elevated Allergic Comorbidity in Patients with Food Protein-Induced Enterocolitis. J Allergy Clin Immunol Pract 8(3): 1039-1046, Mar 2020.
a5 Kennedy K, Muir AB, Grossman A, Brown-Whitehorn T, Cianferoni A, Spergel JM, Furuta GT, Wilkins BJ, Shuker M, Ruffner MA. 88 : Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience. 50 J Allergy Clin Immunol Pract 7(6): 2059-2061, Jul 2019.
18a Wang KY, Lee J, Cianferoni A, Ruffner MA, Dean A, Molleston JM, Pawlowski NA, Heimall J, Saltzman RW, Ram GS, Fiedler J, Gober LM, Spergel JM, Brown-Whitehorn TF: Food Protein-Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral Center. J Allergy Clin Immunol Pract. 7(2): 444-450, Sept 2018.
2c
7
1d
1f
Selected Publications
140 Ruffner MA*, Shoda T*, Lal M, Mrozek Z, Muir AB, Spergel JM, Dellon ES, Rothenberg ME (*contributed equally): Persistent esophageal changes after histologic remission in eosinophilic esophagitis. J Allergy Clin Immunol 153(4): 1063-1072, Apr 2024.17a Spergel BL, Ruffner MA, Godwin BC, Liacouras CA, Cianferoni A, Gober L, Hill DA, Brown-Whitehorn TF, Chaiboonma K, Aceves SA, Muir AM, Spergel JM: Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use. Ann Allergy Asthma Immunol 128(5): 589-593, May 2022.
155 Tran P, Gober L, Garabedian EK, Fuleihan RL, Puck JM, Sullivan KE, Spergel JM, Ruffner MA: Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry. Front Immunol 13(987895): doi: 10.3389, Sep 2022 Notes: epub.
14e Ruffner MA*, Hu A*, Dilollo J, Benocek K, Shows D, Gluck M, Spergel JM, Ziegler SF, Hill DA, Cerosaletti K (*contributed equally): Conserved interferon signature in adult and pediatric eosinophilic esophagitis. Journal of Immunology 206(6): 1361-1371, Mar 2021.
152 Benitez AJ, Bittinger K, Tanes C, Hofstaedter CE, Kim DK, Gross J, Ruffner MA, Albenberg L, Spergel JM, Muir AB: Effect of topical swallowed steroids on the bacterial and fungal esophageal microbiota in eosinophilic esophagitis. Allergy 76(5): 1549-1552, May 2021.
151 Ruffner MA, Zhang Z, Maurer K, Muir AB, Cianferoni C, Sullivan KE, Spergel JS: RNA sequencing identifies global transcriptional changes in peripheral CD4 + cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitis. Clin Transl Immunology 2d 10(7): e1314, July 2021.
c8 Ruffner MA, Song L, Mauer K, Shi L, Wang JX, Muir AB, Spergel JM, Sullivan KE: Toll like receptor 2 stimulation augments esophageal barrier integrity 3d Allergy 74(12): 2449-2460, Dec 2019.
139 Ruffner MA, Wang KY, Dudley JW, Cianferoni A, Grundemeier R, Spergel JM, Brown-Whitehorn TF, Hill DA: Elevated Allergic Comorbidity in Patients with Food Protein-Induced Enterocolitis. J Allergy Clin Immunol Pract 8(3): 1039-1046, Mar 2020.
a5 Kennedy K, Muir AB, Grossman A, Brown-Whitehorn T, Cianferoni A, Spergel JM, Furuta GT, Wilkins BJ, Shuker M, Ruffner MA. 88 : Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience. 50 J Allergy Clin Immunol Pract 7(6): 2059-2061, Jul 2019.
18a Wang KY, Lee J, Cianferoni A, Ruffner MA, Dean A, Molleston JM, Pawlowski NA, Heimall J, Saltzman RW, Ram GS, Fiedler J, Gober LM, Spergel JM, Brown-Whitehorn TF: Food Protein-Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral Center. J Allergy Clin Immunol Pract. 7(2): 444-450, Sept 2018.
2c
4d
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10
c
